Cittadine Andrew Insider Trades

Insider Trading History

Track insider trading activity for Cittadine Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $3.23M 54,240 shares
Last Trade
Mar 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 3,514 shares
$54.79
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $3.14M 52,669 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$86.1k 1,571 shares
$54.79
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.67M 44,753 shares
Last Trade
Mar 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 3,514 shares
$54.79
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.88M 48,267 shares
Last Trade
Dec 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$282k 4,326 shares
$65.30
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $3.14M 52,615 shares
Last Trade
Dec 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$282k 4,326 shares
$65.30
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $3.02M 50,726 shares
Last Trade
Dec 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$123k 1,889 shares
$65.30
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $3.14M 52,593 shares
Last Trade
Dec 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.74M 22,888 shares
$75.94
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.88M 48,289 shares
Last Trade
Sep 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$155k 1,896 shares
$81.67
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.99M 50,185 shares
Last Trade
Sep 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$353k 4,327 shares
$81.67
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.31M 38,674 shares
Last Trade
Sep 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$353k 4,327 shares
$81.67
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.73M 45,858 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$107k 2,990 shares
$35.78
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.56M 43,001 shares
Last Trade
Jun 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 6,863 shares
$35.78
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.91M 48,848 shares
Last Trade
Jun 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 6,863 shares
$35.78
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.5M 41,985 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27.1k 744 shares
$36.41
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.55M 42,729 shares
Last Trade
Mar 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.2k 1,791 shares
$36.41
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $3.08M 51,655 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 43,445 shares
$31.70
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.48M 41,659 shares
Last Trade
Dec 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.4k 1,790 shares
$22.00
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.44M 40,938 shares
Last Trade
Dec 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.9k 721 shares
$22.00
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $660k 11,074 shares
Last Trade
Dec 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.4k 1,790 shares
$22.00
$59.61
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Operating Officer
Holding Value $2.41M 40,404 shares
Last Trade
Sep 30, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.1k 1,791 shares
$6.74
$59.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up